Prot #P11-282: A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Patients with Moderately to Severely Active Ulcerative Colitis (UC)

Project: Research project

Project Details

StatusActive
Effective start/end date10/2/1410/2/24

Funding

  • Mapi USA, Inc. (Prot #P11-282)
  • AbbVie Inc. (Prot #P11-282)